Skip to content
Open access

Non-motor symptoms questionnaire-based profiles in early-stage dementias: A prospective cohort study

Sep 2026 · Journal of Alzheimer's Disease · Vol 114, pp. 267 - 275 · 0 citations · 36 references
Medicine

TL;DR

Non-motor symptom profiles differ among these dementia subtypes even at early stages, suggesting their potential utility as early disease-specific indicators.

Abstract

Background Current knowledge regarding the nature and prevalence of non-motor symptoms across different types of dementia is limited. While Alzheimer's disease (AD), behavioral variant frontotemporal dementia (bvFTD), and dementia with Lewy bodies (DLB) are primarily characterized by cognitive and motor symptoms, several other features such as non-motor symptoms are also known to occur in all these conditions. Objective To assess non-motor symptoms in early-stage dementia and characterize symptom profiles across different neurodegenerative dementia diseases. Methods A total of 64 AD, 38 bvFTD, and 17 DLB early-stage patients, along 63 cognitively healthy controls (HC), were prospectively recruited from Kuopio and Oulu University Hospitals. Non-motor symptoms were evaluated using the Non-Motor Symptoms Questionnaire (NMSQ), focusing on gastrointestinal, neuropsychiatric, cognitive, sleep-related and sensory-motor domains within three timeframes prior to the baseline visit. Results DLB patients exhibited the highest prevalence of non-motor symptoms across all domains. bvFTD and AD patients did not show disease group specific symptoms, but apathy and paranoidal thoughts appeared earlier in bvFTD than AD or DLB. Diplopia was reported by 14% of DLB patients (Fisher exact test, p = 0.035) one year before diagnosis. Neuropsychiatric and cognitive symptoms were more frequent in all dementia groups compared to HC (Fisher exact test, p < 0.01). Conclusions Non-motor symptom profiles differ among these dementia subtypes even at early stages, suggesting their potential utility as early disease-specific indicators.

Read PDF

Similar papers

Open access Oct 2026

A-02: Neuropsychiatric Symptoms Predict Functional Disability Across Parkinsonian Disorders

Objective: Neuropsychiatric symptoms (NPS) are common across parkinsonian disorders. Symptom profiles vary by diagnosis and stage of disease, and individual symptoms may differentially affect everyday functioning. We evaluated the impact of NPS on functional status in Parkinson’s disease (PD), Lewy body disease (LBD)...

Andrea Collins, Jordan Kozuki, Lily Wilkin et al. · 0 citations
Open access Oct 2026

Multidomain Cognitive Decline and Motor Disability in Multiple Sclerosis: A Retrospective Cohort Study

Background: Multiple sclerosis (MS) is characterized by heterogeneous trajectories of motor and cognitive disability. This study aimed to characterize longitudinal cognitive and motor trajectories across MS phenotypes and to identify baseline predictors of subsequent worsening. Methods: This retrospective cohort includ...

Giuseppe Romano, Maria Cropano, M. Fordellone et al. · 0 citations
Open access Oct 2026

Clinical Value of Neuropsychiatric Scales in the Preliminary Identification of Frontotemporal Dementia from Alzheimer's Disease.

OBJECTIVE To provide a reference for the clinical differentiation of behavioural variant frontotemporal dementia (bvFTD) and Alzheimer's disease (AD) by analysing differences in scores across various neuropsychiatric scales and their relationships with activities of daily living and caregiver burden. STUDY DESIGN A c...

Ling-Feng Zhang, Peng-Xing Lin, Yi-Pan Zhang et al. · 0 citations
Open access Oct 2026

Neuropsychological profiles of dementia with lewy bodies according to alzheimer’s disease co-pathology

Alzheimer’s disease (AD) co-pathology is common in dementia with Lewy bodies (DLB) and has been linked to poorer outcomes. However, its associations with domain-specific cognitive performance across the MCI/prodromal and dementia stages, and the relationship between cognitive performance and plasma biomarkers, re...

Elena Vera-Campuzano, Í. Rodríguez-Baz, Carla Abdelnour et al. · 0 citations
Open access Oct 2026

Comorbidity, Cognitive Impairment, and Disease Duration Associated with Quality of Life in Parkinson's Disease

Background: Parkinson’s disease impairs motor and nonmotor functions, potentially reducing health-related quality of life. Evidence regarding the associations of comorbid conditions, cognitive impairment, and disease duration with quality of life in regional healthcare settings remains limited. Objective: To examine th...

Y. Astri, Maudita Nursanti · 0 citations
Open access Oct 2026

Functional and Structural Imaging Features of Cognitive Profiles in Multiple Sclerosis

Background and Objectives Cognitive impairment affects 40%–70% of patients with multiple sclerosis (MS). Although recent hypothesis-driven and data-driven efforts have identified cognitive phenotypes, functional substrates underlying impairment in such phenotypes are still not clear. Our objective was to identify disti...

Kshiteeja Jain, P. Valsasina, Damiano Mistri et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.